Unanswered questions in screening for prostate cancer

European Journal of Cancer

Volumn 36, Issue 10, 2000, Pages 1316-1321

  Neal, D E ^a   Leung, H Y ^a   Powell, P H ^a   Hamdy, F C ^b   Donovan, J L ^c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Prostate cancer; PSA; Radical prostatectomy; Screening

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BLOOD; COST OF ILLNESS; FORECASTING; HUMAN; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PROGNOSIS; PROSTATE TUMOR; PROSTATECTOMY; REVIEW; RISK FACTOR; TIME;

COST OF ILLNESS; FORECASTING; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK FACTORS; TIME FACTORS;

EID: 0034204182     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(00)00104-0     Document Type: Article

References (33)

1. Jensen OM, Esteve J, Renard H. Cancer in the European Community and its member states. Eur J Cancer 1990, 26, 1167-1256.
2. Office of Population Censuses and Surveys. Cancer Stats. Registrations 1991 England & Wales. MB1 No. 20. London, HMSO, 1996.
3. Meikle AW, Smith JA. Epidemiology of prostate cancer. Urologie Clinics of North America 1998, 17, 709-719.
4. McCahy PJ, Harris CA, Neal DE. Breast and prostate cancer in the relatives of men with prostate cancer. Br J Urol 1996, 78, 552-556.
5. Chamberlain J, Melia J, Moss S, Brown J. The diagnosis, management, treatment and costs of prostate cancer in England and Wales. NHS R&D HTA Programme: Health Technology Assessment 1997, 1(3).
6. Selley S, Donovan JL, Faulkner A, Coast J, Gillatt D. Diagnosis, management and screening of early localised prostate cancer. NHS R&D HTA Programme: Health Technology Assessment 1997, 1(2).
7. Wasson JH, Sushman CC, Bruskewitz RC, Littenberg B, Mulley AG, Wennberg JE. A structured literature review of treatment of localized prostate cancer. Arch Fam Med 1993, 2, 487-493.
8. Kramer BS, Brown ML, Prorok PC, et al. Prostate cancer screening: what we know and what we need to know. Ann Int Med 1993, 119, 914-923.
9. Stewart-Brown S, Farmer A. Screening could seriously damage your health. Br Med J 1997, 314, 533.
10. UK experts advise against prostate cancer screening. Lancet 1997, 349, 1-2.
11. Woolf SH. Should we screen for prostate cancer? Br Med J 1997, 314, 989-990.
12. Cadman D, et al. Assessing community screening programs. JAMA 1984, 251, 1580-1585.
13. Wilson JMG, Jungner G. Principles and practice of screening for disease. Public Health Papers 1990, 34.
14. Peters TJ, Wildschut HU, Weiner CP. Epidemiologie considerations in screening. In Wildschut HU, Weiner CP, Peters TJ, eds. When to Screen in Obstetrics and Gynaecology. London, WB Saunders Ltd, 1996.
15. Whitmore WF. Localized prostate cancer: management and detection issues. Lancet 1994, 343, 1263-1267.
16. Coplen DE, Andriole GL, Yuan JJ, Catalona WJ. The ability of systematic transectal ultrasound guided biopsy to detect prostate cancer in men with the clinical diagnosis of benign prostatic hyperplasia. J Urol 1991, 146, 75-77.
17. Hammerer P, Huland H. Systematic sextant biopsies in 651 patients referred for prostate evaluation. J Urol 1994, 151, 99-101.
18. Smith DS, Catalona WJ. The nature of prostate-cancer detected through prostate-specific antigen based screening. J Urol 1994, 152, 1732-1736.5.
19. Reissigl A, Pointner J, Horninger W, et al. PSA-based screening for prostate cancer in asymptomatic younger males: pilot study in blood donors. Prostate 1997, 30, 20-25.
20. Beemsterboer PMM, Kranse R, deKoning HJ, Habbema JDF, Schroder FH. Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam). Int J Cancer 1999, 84, 437-441.
21. Catalona WJ, Smith DS, Ornstein DK. Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination - Enhancement of specificity with free PSA measurements. JAMA 1997, 277, 1452-1455.
22. Collins MM, Ransohoff DF, Barry MJ. Early detection of prostate cancer - Serendipity strikes again. JAMA 1997, 278, 1516-1519.
23. Carter HB, Sauvageot J, Walsh PC, Epstein JL Prospective evaluation of men with stage Tic adenoacarcinoma of the prostate. J Urol 1997, 157, 2206-2209.
24. Litwin MS, Hays RD, Fink A, Ganz PA. Quality of Life outcomes in men treated for localized prostate cancer. JAMA 1995, 273, 129-135.
25. Adolfsson J, Steineck G, Whitmore WF. Recent results of management of palpable clinically localized prostate cancer. Cancer 1993, 72, 310-322.
26. Wasson JH, Sushman CC, Bruskewitz RC, Littenberg B, Mulley AG, Wennberg JE. A structured literature review of treatment of localized prostate cancer. Arch Fain Med 1993, 2, 487-493.
27. Spitz MR, Currier RD, Fueger JJ, et al. Familial patterns of prostate cancer: a case-control analysis. J Urol 1991, 146, 1305-1307.
28. McWhorter WP, Hernandez AD, Meikle AW, et al. A screening study of prostate cancer in high risk families. J Urol 1992, 148, 826-828.
29. Hankey BF, Feuer EJ, Clegg LX, et al. Cancer surveillance series: interpreting trends in prostate cancer - Part I: evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst 1999, 9, 1017-1024.
30. Feuer EJ, Merrill RM, Hankey BF. Cancer surveillance series: interpreting trends in prostate cancer - Part II: cause of death misclassification and the recent rise and fall in prostate cancer mortality. J Natl Cancer Inst 1999, 91, 1025-1032.
31. Etzioni R, Legier JM, Feuer EJ, Merrill RM, Cronin KA, Hankey BF. Cancer surveillance series: Interpreting trends in prostate cancer - Part III: quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality. J Natl Cancer Inst 1999, 91, 1033-1039.
32. Bangma CH, Rietbergen JBW, Kranse R, Blijenberg BG, Petterson K, Schröder FH. The free-to-total prostate specific antigen ratio improves the specificity of prostate specific antigen in screening for prostate cancer in the general population. J Urol 1997, 157, 2191-2196.
33. Neal DE, Donovan J. Screening for prostate cancer. Ann Oncol 1998, 9, 1289-1292.